1. Nonsegmental Vitiligo {#sec1}
========================

Nonsegmental vitiligo is acquired depigmented skin lesions mainly caused by autoimmune loss of melanocytes. Genetic and environmental factors are involved in the development. Recent genetic studies identified predisposed genes involving the development of nonsegmental vitiligo \[[@B1]--[@B5]\]. Current histopathological studies showed increased infiltration of dendritic cells, Th17 cells \[[@B6]\], and CD8+ cytotoxic T lymphocytes \[[@B7]--[@B10]\] in the margin of vitiligo and the reduced number of regulatory T (Treg) cells in the affected skin \[[@B11], [@B12]\].

2. Genetics in Nonsegmental Vitiligo {#sec2}
====================================

Genome-wide association studies are applied for identifying the candidate genes in multifactor-associated disorders such as nonsegmental vitiligo \[[@B1]--[@B5]\]. In 2007, NALP1 was revealed to be associated with the risk of nonsegmental vitiligo in Caucasians \[[@B1]\]. The subsequent studies in Caucasians identified multiple loci on major-histocompatibility-complex (MHC) class I molecules, MHC class II molecules, *PTPN22*, *LPP*, *IL2RA*, *UBASH3A*, *C1QTNF6*, *RERE*, *GZMB*, *TYR*, *FOXP1*, *CCR6*, *TSLP*, *XBP1*, and *FOXP3* \[[@B2]--[@B4]\]. Another study in Chinese Han population detected two independent loci within the MHC region and a locus at 6q27 containing *RNASET2*, *FGFR1OP*, and *CCR6* \[[@B5]\]. The current candidate genes of nonsegmental vitiligo are summarized in [Table 1](#tab1){ref-type="table"} \[[@B13]--[@B91]\]. These genes are classified into (i) autoantigen, (ii) innate immunity, (iii) innate and acquired immunity, and (iv) other function and miscellaneous. Importantly, nonsegmental vitiligo-susceptible genes are often involved in other autoimmune disorders. Further study is needed to identify additional nonsegmental vitiligo susceptible genes and to elucidate the pathologic mechanism of the genes in nonsegmental vitiligo.

3. Immunology in Nonsegmental Vitiligo {#sec3}
======================================

Nonsegmental vitiligo can be caused by an immunologically complex mechanism. A variety of melanocytes-expressing proteins have been identified as autoantigens. Cui et al. showed that 24 (83%) of 29 vitiligo patients had autoantibody to melanocytes-associated autoantigen versus 2 (7%) of 28 healthy controls \[[@B92]\]. Until now, various proteins have been detected as autoantigens including tyrosinase \[[@B93]--[@B95]\], tyrosinase-related protein 1 \[[@B96]--[@B99]\], tyrosinase-related protein 2 \[[@B96], [@B100]\], Pmel17 \[[@B101], [@B102]\], melanin-concentrating hormone receptor 1 \[[@B103]\], tyrosine hydroxylase \[[@B104]\], and lamin A \[[@B99]\]. Antityrosine hydroxylase autoantibody was more frequent in active vitiligo patients \[[@B104]\], suggesting potency as an activity marker. Using radioimmunoassay, Waterman et al. found positive antibody reactivity to gamma-enolase (8%), alpha-enolase (9%), heat-shock protein 90 (13%), osteopontin (4%), ubiquitin-conjugating enzyme (15%), translation-initiation factor 2 (6%), and Rab38 (guanosine-5′-triphosphate- (GTP-) binding protein) (15%) in nonsegmental vitiligo patient sera \[[@B105]\]. Melanocyte-specific antibodies might induce apoptosis of melanocytes \[[@B106]\]. Ruiz-Argüelles et al. reported that serum immunoglobulin G antibodies from vitiligo patients were able to penetrate cultured melanocytes *in vitro* and trigger apoptosis \[[@B106]\]. However, further investigations are required to elucidate the pathogenetic function of autoantibodies \[[@B107]\].

Histopathological studies demonstrated the increased dendritic cells \[[@B6]\], Th17 cells \[[@B6], [@B108]\], and CD8+ cytotoxic T lymphocytes \[[@B7]--[@B10]\] and the decreased naturally occurring CD4+CD25+FOXP3+ Treg cells \[[@B11], [@B12]\] at the margin of vitiligo lesions. The infiltrating cytotoxic CD8+ T cells recognize melanocyte-associated autoantigens and enable to locate at dermal-epidermal junctions \[[@B109]\]. The paucity of Treg in vitiligo skin causes perpetual antimelanocyte reactivity in nonsegmental vitiligo \[[@B110], [@B111]\]. The role of Treg and Th17 cells should be elucidated in order to understand the balance between the occurrence and suppression of the autoimmune reaction.

The activation of inflammasome constructed by NOD-like receptors such as NALP-1 overproduces proinflammatory cytokines of IL-1*β* and IL-18, inducing apoptosis \[[@B112]\]. Interestingly, Wang et al. showed the increased IL-1*β* level in the vitiligo lesion and the expression of NALP-1 in the activated epidermal Langerhans cells and dermal dendritic cells \[[@B6]\]. As IL-1*β* is the essential cytokine to develop Th17 cells \[[@B6]\], IL-1*β* produced by activated inflammasome may involve the development of *nonsegmental* vitiligo.

4. Conclusion {#sec4}
=============

Considerable progress is being made towards understanding the pathogenesis of nonsegmental vitiligo. Although a number of genes have been implicated by well-designed genome-wide association studies, we do not have good genotype-phenotype correlations. In the future, we can anticipate further advancement regarding specific interactions between disease-susceptible genes and gene-environment interactions.
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Genes associated with nonsegmental vitiligo.

  Gene                                                                                                         Function                                                                                                                                                                                                  Involved in other autoimmune diseases   Reference
  ------------------------------------------------------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------- ------------------------------------
  \(1\) Autoantigen                                                                                                                                                                                                                                                                                                                                              
  * TYR*                                                                                                       Production of melanin granules in melanosomes                                                                                                                                                                                                     
  \(2\) Innate immunity                                                                                                                                                                                                                                                                                                                                          
  * NALP1*                                                                                                     Inflammasome activation and release of proinflammatory cytokines such as IL-1*β* and IL-18                                                                                                                T1D, AD, CeD                            \[[@B13]--[@B20]\]
  * PTEN22*                                                                                                    A lymphoid tyrosine phosphatase of the protein-tyrosine phosphatase family controlling the signal from antigen receptors, costimulatory receptors, and cytokine receptors                                 GD, AA, RA, SLE, T1D, AD                \[[@B21]--[@B30]\]
  \(3\) Adaptive immunity                                                                                                                                                                                                                                                                                                                                        
   MHC                                                                                                         Major histocompatibility complex class I and II proteins being indispensable for antigen presentation                                                                                                     AT, AA, RA, SLE, T1D, PS                \[[@B31]--[@B43]\]
  * FOXP3*                                                                                                     A functional marker for naturally occurring, thymus-selected CD4+CD25+FOXP3+ regulatory T cells                                                                                                           AT, T1D                                 \[[@B44]--[@B54]\]
  * IL2RA*(CD25)                                                                                               T-cell proliferation and a functional marker for naturally occurring, thymus-selected CD4+CD25+FOXP3+ regulatory T cells                                                                                  GD, AA, RA, SLE, T1D, PS, PS,           \[[@B35], [@B51], [@B55]--[@B65]\]
  * CCR6*                                                                                                      The CCR6/CCL20 chemokine receptor/ligand axis providing key homing signals recruiting both proinflammatory and suppressive T cell subsets                                                                 GD, RA                                  \[[@B55], [@B66]--[@B69]\]
  * TSLP*                                                                                                      Induction of allogeneic naive T cells to differentiate into cytotoxic T cells, and induction of the proliferation and differentiation of CD4+CD8-CD25-thymocytes into CD4+CD25+FOXP3+ regulatory T cell                                           \[[@B70]--[@B72]\]
  \(4\) Innate and adaptive immunity                                                                                                                                                                                                                                                                                                                             
   GZMB                                                                                                        \(1\) A family of conserved serine proteases stored within the cytotoxic granules of cytotoxic lymphocytes                                                                                                                                        \[[@B73], [@B74]\]
  \(2\) The formation of blebs containing various subcellular compartments on the surface of apoptotic cells                                                                                                                                                                                                                                                     
  \(3\) Supply of these peptides for autoimmune response                                                                                                                                                                                                                                                                                                         
  * XBP1*                                                                                                      Protective roles against oxidative stress, and unfolded protein response of a stress response to increased levels of unfolded proteins in the endoplasmic reticulum                                                                               \[[@B75]--[@B80]\]
  \(5\) Other function and miscellaneous                                                                                                                                                                                                                                                                                                                         
  * LPP*                                                                                                       Involvement of cell-cell adhesion and cell motility                                                                                                                                                       RA, T1D, CeD                            \[[@B81]--[@B84]\]
  * UBASH3A*                                                                                                   Involvement of growth factor withdrawal-induced apoptosis in T cells                                                                                                                                      RA, T1D, CeD                            \[[@B85]--[@B89]\]
  * C1QTNF6*                                                                                                   Unknown                                                                                                                                                                                                   RA, T1D, CeD                            \[[@B90], [@B91]\]
  * FOXP1*                                                                                                     A role in cardiac, lung, and lymphocyte development, and tumor-suppressive function                                                                                                                                                               

AA: alopecia areata, AD: Addison\'s disease, AT: autoimmune thyroiditis, CeD: celiac disease, GD: Graves\' disease, IL: interleukin, PS: psoriasis, PA: psoriatic arthritis, RA: rheumatoid arthritis, SLE: systemic lupus erythematosus, and T1D: type 1 diabetes.
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